MILESTONE PHARMACEUTICALS IN (MIST)
CA59935V1076 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 13.76M | 7.60M | 114.10M | 72.30M | 119.80M | |||
| Marketable Securities | 52.24M | 56.90M | 0.00 | 70.00M | 0.00 | |||
| Receivables | 3.85M | 1.20M | 500.00K | 900.00K | 800.00K | |||
| Other Current Assets | 3.18M | 6.00M | 4.30M | 5.40M | 1.80M | |||
| Total Current Assets | 73.03M | 71.80M | 118.90M | 148.70M | 122.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.19M | 2.70M | 900.00K | 1.30M | 900.00K | |||
| Total Non-Current Assets | 2.19M | 2.70M | 900.00K | 1.30M | 900.00K | |||
| TOTAL ASSETS | 75.23M | 74.50M | 119.80M | 150.00M | 123.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.25M | 3.90M | 2.40M | 1.50M | 4.00M | |||
| Accounts Payable | 3.98M | 2.30M | 4.40M | 4.60M | 4.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 7.23M | 6.10M | 6.80M | 6.20M | 8.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 49.77M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.46M | 2.00M | 500.00K | 700.00K | 200.00K | |||
| Total Non-Current Liabilities | 51.23M | 2.00M | 400.00K | 700.00K | 200.00K | |||
| TOTAL LIABILITIES | 58.45M | 8.10M | 7.20M | 6.90M | 8.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -277.57M | -232.00M | -153.40M | -115.50M | -113.50M | |||
| Additional Paid In Capital | 33.83M | 24.40M | 15.70M | 8.50M | 3.80M | |||
| Common Shares | 260.50M | 273.90M | 251.90M | 251.70M | 226.20M | |||
| Other Shareholders' Equity | N/A | N/A | -1.60M | -1.60M | -1.60M | |||
| Shares Outstanding | 33.48M | 34.30M | 29.90M | 29.80M | 24.50M | |||
| Tangible Book Value per Share | 0.50 | 1.93 | 3.77 | 4.80 | 4.69 | |||
| Total Shareholders' Equity | 16.77M | 66.30M | 112.60M | 143.10M | 114.90M | |||
| TOTAL LIABILITIES AND EQUITY | 75.23M | 74.50M | 119.80M | 150.00M | 123.40M | |||
| Statistics | ||||||||
| Debt/Equity | 2.97 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.11 | 11.77 | 17.49 | 23.98 | 14.76 | |||
| Return On Assets (ROA) | -79.34% | -78.38% | -35.77% | -33.31% | -44.76% | |||
| Return On Equity (ROE) | -355.88% | -88.07% | -38.06% | -34.92% | -48.07% | |||
All data in USD